What If your arteries could clean themselves? Scientists just built “Plaque-Eating” nanoparticles

Most heart attacks don’t come with a warning. No loud alarm. No countdown. Just a silent buildup inside your arteries that one day turns deadly.

That buildup is called plaque — a dangerous mix of dead cells, cholesterol, and inflammation clinging to artery walls. For decades, medicine has focused on slowing plaque down: lowering cholesterol, controlling blood pressure, reducing risk.

But now, scientists are asking a far bolder question: What if we could make plaque disappear?

Researchers supported by the U.S. National Heart, Lung, and Blood Institute have developed something that sounds straight out of science fiction — plaque-eating nanoparticles.

These microscopic particles are designed to slip into the most dangerous plaques in the body, acting like a biological Trojan horse. Once inside, they target immune cells called macrophages — the body’s natural cleanup crew that, over time, becomes overwhelmed and dysfunctional inside clogged arteries.

Here’s the twist: instead of attacking plaque directly, the nanoparticles reprogram these immune cells. They deliver a drug that tells macrophages to start doing their job again — clearing out dead and dying cells that make plaques unstable and prone to rupture.

In animal studies, this approach didn’t just shrink plaques. It helped stabilize them, making them less likely to trigger heart attacks or strokes. Even more surprising, the treatment appeared highly targeted, with minimal side effects, because the nanoparticles homed in on diseased tissue rather than healthy cells.

Why does this matter so much?

Because today’s treatments don’t actually remove plaque — they manage the conditions around it. This research flips the script by using the body’s own immune system to clean arteries from the inside out.

To be clear, this technology is still in early, pre-clinical stages and hasn’t yet been tested in humans. There’s a long road between promising lab results and real-world treatments. But if this approach holds up in human trials, it could mean fewer sudden heart attacks, fewer emergency procedures, and more opportunities to intervene before symptoms ever appear.

Not a miracle cure — but a meaningful step toward preventing heart attacks before they have the chance to strike.